Nanomedicine in Translational Research

Status and Future Challenges
Herausgeber: Kamalasanan, Kaladhar; Sharma, Chandra P

• Broschiertes Buch

Produktbeschreibung

Nanomedicine in Translational Research: Status and Future Challenges harnesses the current developments and future directions of diagnostic and therapeutic solutions in clinical scenarios. This book integrates nanomedicine and biomaterials to develop healthcare technology for improved patient care and clinical practices, through applications using theranostics, biomaterials, 3-D printing, regenerative medicines, and nanosystems. Those in this multidisciplinary field will need to improve procedures and protocols, as well as regulatory guidelines and their clinical implications. This book will be highly useful as it is written by experts in the field for researchers working in the areas of nanotechnology, biomaterials, drug delivery, and pharmaceuticals for chronic diseases.

Produktdetails

• Verlag: Elsevier Science
• Seitenzahl: 426
• Erscheinungstermin: 24. September 2024
• Englisch
• Gewicht: 870g
• ISBN-13: 9780443222573
• ISBN-10: 0443222576
• Artikelnr.: 69928978

Inhaltsangabe

1. Introduction
2. Properties of biomaterials at nano range
3. In vitro systems to demonstrate the nano effect
4. Toxicology of biomaterials at nanoscale
5. Porphyrinoid-based single molecule to nano theranostics towards
personalized diagnosis and treatment
6. Nanomaterials for biomedical applications
7. Nanosystems - combination products
8. Biomass derived carbon nanodots
9. Nanosystems for Pharmaceutical applications
10. Scope of Biomaterials for theranostics application
11. Redox Nanotherapeutics: Fundamentals and Applications
12. Smart Therapeutics: Evolution from small biomolecules to synthetic
cells
13. Applications of Artificial Intelligence and Machine Learning Models
in Nanotherapeutics.
14. Nanomedicine in Patient-specific Clinical Trend: Shape memory
polymers of emerging biomedical applications and their future
prospects
15. Commercialized nanomedicines until to date
16. Nanosystems development, Quality Control requirements and ethical
issues
17. Affordable and accessible nanomedicines: Regulatory perspectives from
right to health